| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/20/2002 | EP1187908A1 42 human secreted proteins |
| 03/20/2002 | EP1187852A1 EXPRESSION AND EXPORT OF INTERFERON-ALPHA PROTEINS AS Fc FUSION PROTEINS |
| 03/20/2002 | EP1187843A1 Angiogenic proteins and uses thereof |
| 03/20/2002 | EP1187834A1 Polymorphs of crystalline (2-benzhydryl-1-azabicyclo[2,2,2]oct-3-yl)-(5-isopropyl-2-methoxybenzyl)-ammoniumchloride as nk-1 receptor antagonists |
| 03/20/2002 | EP1187827A1 Antiviral agents |
| 03/20/2002 | EP1187821A1 Benzofuranylsulfonates |
| 03/20/2002 | EP1187817A1 Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same |
| 03/20/2002 | EP1187816A1 5-cyano-2-aminopyrimidine derivatives |
| 03/20/2002 | EP1187815A1 4-phenyl-pyrimidine derivatives |
| 03/20/2002 | EP1187814A2 5-phenyl-pyrimidine derivatives |
| 03/20/2002 | EP1187813A1 Azolylbenzamides and analogues and their use for treating osteoporosis |
| 03/20/2002 | EP1187811A1 Inhibitors of metalloproteinases |
| 03/20/2002 | EP1187810A2 Heterocyclic analgesic compounds and their use |
| 03/20/2002 | EP1187635A1 Anaesthetic formulation comprising an nmda-antagonist and an alpha-2 adrenergic agonist |
| 03/20/2002 | EP1187629A2 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 03/20/2002 | EP1187624A1 Conformationally constrained backbone cyclized interleukin-6 antagonists |
| 03/20/2002 | EP1187620A1 Antisense modulation of b7 protein expression |
| 03/20/2002 | EP1187619A1 Anti-tumor agents comprising boroproline compounds |
| 03/20/2002 | EP1187617A2 Topical ophthalmic mast cell stabilizers for treating allergic eye diseases |
| 03/20/2002 | EP1187616A1 Thrombin inhibitors |
| 03/20/2002 | EP1187613A1 Amide substituted imidazoquinolines |
| 03/20/2002 | EP1187608A1 Indole compounds |
| 03/20/2002 | EP1187592A2 Alpha v integrin receptor antagonists |
| 03/20/2002 | EP1137415A4 Myt1 kinase inhibitors |
| 03/20/2002 | EP1090029B1 14,15-cyclopropanosteroids of the 19-norandrostane series, method for the production thereof and pharmaceutical preparations containing said compounds |
| 03/20/2002 | EP1077687B1 Multiparticulate pharmaceutical form with programmed and timed release and preparation method |
| 03/20/2002 | EP1019050B1 Use of somatostatin agonists and antagonists for treating diseases related to the eye |
| 03/20/2002 | EP0960110B1 3-ARYL SUBSTITUTED PYRAZOLO 4,3-d]PYRIMIDINE DERIVATIVES; CORTICOTROPIN-RELEASING FACTOR RECEPTOR (CRF 1?) SPECIFIC LIGANDS |
| 03/20/2002 | EP0948340B1 Biologically active substances, method for obtaining and compositions containing them |
| 03/20/2002 | EP0944587B1 Metalloproteinase inhibitors |
| 03/20/2002 | EP0937037B1 Sodium salt of [poly-(2,5-dihydroxyphenylene)]-4-thiosulphuric acid of linear structure as regulator of cell metabolism and production method thereof |
| 03/20/2002 | EP0888356B1 Condensed 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors |
| 03/20/2002 | EP0871446B1 Use of eliprodil for the manufacture of a medicament for the treatment of ischemic disorders of the retina or the optic nerve |
| 03/20/2002 | EP0837860B1 TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO(3,4-c]-1,2,4-TRIAZOLO(4,3-ALPHA]PYRIDINES |
| 03/20/2002 | EP0800829B1 Antitumor agent potentiator comprising il-6 antagonist |
| 03/20/2002 | EP0777680B1 Urokinase receptor ligands |
| 03/20/2002 | EP0642351B1 New pharmaceutical uses of krill enzymes |
| 03/20/2002 | EP0610475B1 Nerve-derived transglutaminase enzyme useful for inducing nerve regeneration |
| 03/20/2002 | CN1341099A 2-aminopyridines containing fused ring substituents |
| 03/20/2002 | CN1341098A W-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 03/20/2002 | CN1341027A Inhibitors for use in hemostasis and immune function |
| 03/20/2002 | CN1341026A Small peptides and methods for treatment of asthma and inflammation |
| 03/20/2002 | CN1341025A Drugs containing sulfopyranosylacylglycerol derivatives |
| 03/20/2002 | CN1081187C Inhibitors of prenuyl transferases |
| 03/20/2002 | CN1081184C Fluorinated vitamin D3 analogs |
| 03/20/2002 | CN1081065C Compound oral liquid of cactus |
| 03/19/2002 | US6359167 Stable NO-delivering compounds |
| 03/19/2002 | US6359158 A 16-hydroxyeicosatetraenoic acid antagonist; antiinflammatory agents |
| 03/19/2002 | US6359145 Imidazole compounds |
| 03/19/2002 | US6359138 4-hydroxy-piperidine derivatives |
| 03/19/2002 | US6359130 Bridged indenopyrrolocarbazoles |
| 03/19/2002 | US6359127 Oligonucleotide for use in treatment of cancer and nervous system disorders |
| 03/19/2002 | US6359119 Reacting a metal in permetallate form in a mixture with carbon monoxide and a reducing agent comprising stannous salt to form carbonyl complex |
| 03/19/2002 | US6359112 Peptides used as agonists and/or inhibitors of amyloid formation and cytotoxicity and also for use in alzheimer's disease, in type II diabetes mellitus and in spongiform encephalophathies |
| 03/19/2002 | US6359012 Method for making 24(S)-hydroxyvitamin D2 |
| 03/19/2002 | US6359008 Improved bioavailability of drugs and nutrients by permeabilizing cell membranes of organisms, in particular animals and fish; preferably contain a long chain alkyl or alkenyl group, such as a palmitoyl or oleate group |
| 03/19/2002 | US6359002 Method for treating a patient with neoplasia by treatment with a platinum coordination complex |
| 03/19/2002 | US6359001 Use of α-methyl-p-tyrosine to inhibit melanin production in iris melanocytes |
| 03/19/2002 | US6358994 2-acylaminopropanamines as tachykinin receptor antagonists |
| 03/19/2002 | US6358991 By administering indole compounds such as 1-(4-(2-azepan-1yl-ethoxy)-benzyl)-2-(4-hydroxy-phenyl)-3-methyl-1h-indol-5 -ol; epilepsy, asthma, eating disorders, obesity, neurodegenertive conditions, schizophrenia |
| 03/19/2002 | US6358989 Therapeutic inhibitor of vascular smooth muscle cells |
| 03/19/2002 | US6358987 For therapy and prophylaxis of rheumatoid arthritis, osteoarthritis, osteopenias such as osteoporosis, periodontitis, gingivitis, corneal epidermal or gastric ulceration, and tumour metastasis, invasion and growth |
| 03/19/2002 | US6358985 Inhibitors of prenyl-protein transferase |
| 03/19/2002 | US6358984 For therapy of hypertension and/or diseases such as heart and renal diseases |
| 03/19/2002 | US6358983 Heterocyclically substituted α-hydroxycarboxylic acid derivatives, method for producing the same and their use as endothelin receptor antagonists |
| 03/19/2002 | US6358982 Heterocyclyl sulphonamide derivatives |
| 03/19/2002 | US6358978 Substituted benzimidazoles |
| 03/19/2002 | US6358977 Therapy of neurodevelopmental disorder such as autistic spectrum disorders/autistic continuum disorders, pervasive developmental disorders, attention deficit hyperactivity disorder, etc., by administering piperidinemethanol compound |
| 03/19/2002 | US6358976 For therapy and prophylaxis of cancer metastasis, diabetic retinopathy, neovascular glaucoma, thrombosis, restenosis, osteoporosis, or macular degeneration |
| 03/19/2002 | US6358974 Used as as modulators of dopamine d.sub.3 receptors, in therapy as antipsychotic agents |
| 03/19/2002 | US6358973 For therapy of allergic or inflammatory disease |
| 03/19/2002 | US6358972 5-HT1F agonists |
| 03/19/2002 | US6358970 Integrin receptor antagonists |
| 03/19/2002 | US6358965 Use of benzoylalkyl-1,2,3,6-tetrahydropyridines |
| 03/19/2002 | US6358961 Farnesyltransferase inhibiting quinazolinones |
| 03/19/2002 | US6358958 Arylpiperazines having activity at the serotonin 1A receptor |
| 03/19/2002 | US6358956 Inhibitors of prenyl-protein transferase |
| 03/19/2002 | US6358954 PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 03/19/2002 | US6358952 Combination of benzoquinazoline antifolates and protecting agents |
| 03/19/2002 | US6358946 C-6 ring-substituted pyrido[1,2-a]benzimidazole derivatives useful in treating central nervous system disorders |
| 03/19/2002 | US6358945 Compounds useful as anti-inflammatory agents |
| 03/19/2002 | US6358934 Administering viricide to treat human t-cell leukemia/lymphoma and hepatitis virus infections; acquired immunodeficiency syndrome (aids) treatment |
| 03/19/2002 | US6358925 Administering insulin-like growth factor |
| 03/19/2002 | US6358920 Nonapeptide anticarcinogenic and antimetastasis agents |
| 03/19/2002 | US6358741 Polynucleotide coding propagation regulator; for treating cell proliferative defects |
| 03/19/2002 | US6358732 Nucleotide sequences preferential polypeptides for use in the treatment of defects in central nervous system |
| 03/19/2002 | US6358698 Determing antipsychotic activity of compounds by exposing a serotonin receptor having wild type activity with a test compound; then measure basal activity of the receptor; decreased activity indicates antipsychotic drug compound |
| 03/19/2002 | US6358539 To supplement collagen and elastic tissues and thicken the dermis to reduce or eliminate the appearance of cellulite |
| 03/19/2002 | US6358536 Nitric oxide donor compositions, methods, apparatus, and kits for preventing or alleviating vasoconstriction or vasospasm in a mammal |
| 03/19/2002 | US6358527 Administering tablet comprising galanthamine hydrobromide, carrier comprising lactose monohydrate, microcrystalline cellulose and polymer disintegrant for therapy of dementia, mania or nicotine dependence |
| 03/19/2002 | US6358522 For reducing anal leakage of oil in a patient to whom orlistat is being administered |
| 03/19/2002 | US6358491 Somatostatin analogs |
| 03/19/2002 | US6357163 Use of nucleic acid analogues in diagnostics and analytical procedures |
| 03/19/2002 | CA2319966A1 Improved dextran-hemoglobin conjugate as potential blood substitute |
| 03/19/2002 | CA2251453C 5-arylalkyl-substituted pyrazolo(4,3-d)pyrimidine-7-ones |
| 03/19/2002 | CA2236673C (-)cis-6(s)-phenyl-5(r)-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol d-tartrate |
| 03/19/2002 | CA2206804C Trisubstituted thioxanthines |
| 03/19/2002 | CA2193384C Use of gabapentin in the treatment of anxiety and panic |
| 03/19/2002 | CA2179521C 2,4-disulphophenyl butylnitrone, its salts and their use as pharmaceuti cal spintraps |
| 03/19/2002 | CA2128359C New benzospiroalkene derivatives, their preparation process and pharmaceutical compositions containing them |